Combining Domestic and Foreign Investment to Expand Tuberculosis Control in China
article has not abstract
Vyšlo v časopise:
Combining Domestic and Foreign Investment to Expand Tuberculosis Control in China. PLoS Med 7(11): e32767. doi:10.1371/journal.pmed.1000371
Kategorie:
Policy Forum
prolekare.web.journal.doi_sk:
https://doi.org/10.1371/journal.pmed.1000371
Souhrn
article has not abstract
Zdroje
1. World Health Organization 2009 Global Tuberculosis Control 2009: Epidemiology, strategy, finances. Geneva World Health Organization
2. World Health Organization and Stop TB Partnership 2007 The Action Plan for Global MDR-TB and XDR-TB Control, 2007-2008. World Health Organization
3. Ministry of Health P. R. China 2009 Report on status of national notifiable diseases in 2009. Ministry of Health P. R. China. Available: http://www.moh.gov.cn. Accessed 10 January 10 2010
4. RaviglioneMC
UplekarMW
2006 WHO's new Stop TB Strategy. Lancet 18 952 955
5. DyeC
ZhaoFZ
ScheeleS
WilliamsB
2000 Evaluating the impact of tuberculosis control: number of deaths prevented by short-course chemotherapy in China. Int J Epidemiol 29 558 564
6. China Tuberculosis Control Collaboration 2004 The effect of tuberculosis control in China. Lancet 364 417 422
7. WangL
LiuJ
ChinDP
2007 Progress in tuberculosis control and the evolving public-health system in China. Lancet 369 691 696
8. FloydK
AroraVK
MurthyKJ
LonnrothK
SinglaN
2006 Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India. Bull World Health Organ 84 437 445
9. HerdR
HuYW
KoenV
2010 Improving China's health care system. OECD Economics Department Working Papers 751
10. DongKY
2009 Medical insurance system evolution in China. China Econ Rev 20 591 597
11. ChenZ
2007 New rural cooperative medical service will cover around whole country by 2008. Xinhua 2007; 09 05
12. ChenZ
2009 Launch of the health-care reform plan in China. Lancet 373 1322 1324
Štítky
Interné lekárstvoČlánok vyšiel v časopise
PLOS Medicine
2010 Číslo 11
- Statinová intolerance
- Očkování proti virové hemoragické horečce Ebola experimentální vakcínou rVSVDG-ZEBOV-GP
- Co dělat při intoleranci statinů?
- Pleiotropní účinky statinů na kardiovaskulární systém
- DESATORO PRE PRAX: Aktuálne odporúčanie ESPEN pre nutričný manažment u pacientov s COVID-19
Najčítanejšie v tomto čísle
- Doctors and Drug Companies: Still Cozy after All These Years
- Strategies for Increasing Recruitment to Randomised Controlled Trials: Systematic Review
- Prescription Medicines and the Risk of Road Traffic Crashes: A French Registry-Based Study
- Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial